 | |
| Clinical data | |
|---|---|
| Trade names | Metilbisexovis |
| Other names | Methylandrostenediol propionate; Methylandrostenediol 3β-propionate; 17α-Methylandrost-5-ene-3β,17β-diol 3β-propionate |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H36O3 |
| Molar mass | 360.538 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methandriol propionate (brand nameMetilbisexovis), ormethylandrostenediol propionate, also known as17α-methylandrost-5-ene-3β,17β-diol 3β-propionate, is asynthetic,injectedanabolic-androgenic steroid (AAS) and a17α-alkylatedderivative of5-androstenediol that is or was marketed by Vister inItaly.[1][2][3] It is anandrogen ester – specifically, the C3,17βpropionateester ofmethandriol (17α-methyl-5-androstenediol) – and acts as aprodrug of methandriol in the body.[1] Methandriol propionate is administered byintramuscular injection and, relative to methandriol, has an extended duration via this route due to adepot effect afforded by itsester.[citation needed]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
